Baxter International | BAX - SCHULD

Aktienkurs
16.57
Täglich Wechseln
-0.08 -0.48%
Monatlich
-7.48%
Jährlich
-40.76%
Q2 Prognose
16.18




SCHULD Veränderung Datum
Abbott USD 12.94B 496M 2025-09
AngioDynamics USD 6.3M 6.3M 2025-02
Artivion USD 317.78M 619K 2024-12
AtriCure USD 76.73M 521K 2025-09
Avanos Medical USD 133.7M 3.6M 2025-09
Baxter International USD 9.71B 13M 2025-09
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 12.05B 19M 2025-09
Cooper Companies USD 2.51B 27M 2025-09
Dexcom USD 1.24B 1.21B 2025-12
Edwards Lifesciences USD 700.3M 2.3M 2025-09
Fresenius EUR 12.85B 778M 2025-06
Globus Medical USD 119.34M 1.76M 2025-09
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
ICU Medical USD 1.28B 79.88M 2025-12
Inogen USD 0 0 2022-06
Insulet USD 1.01B 384.9M 2025-09
Integra LifeSciences USD 2.01B 7.91M 2025-09
Intuitive Surgical USD 0 0 2025-03
J&J USD 45.8B 4.97B 2025-09
Laboratory Of America USD 6.53B 16.1M 2025-09
Masimo USD 586.2M 56M 2025-09
Medtronic USD 28.07B 1.03B 2025-12
Merit Medical Systems USD 821.15M 599K 2025-09
Quest Diagnostics USD 6.38B 2M 2025-09
Smith & Nephew USD 3.32B 334M 2024-12
Stryker USD 14.86B 1.74B 2025-12
Tandem Diabetes Care USD 449.28M 276K 2025-09
Teleflex USD 2.77B 774M 2025-09
Terumo JPY 159.87B 14.97B 2025-09
Zimmer Biomet Holdings USD 7.52B 593.5M 2025-12